Case number 1:23-cv-00623
Horizon Therapeutics USA Inc. et al v. Dr. Reddys Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 29, 2023 | N/A | Pro Hac Vice Attorney Jonathan R. Davies, Daniel J. Knauss, Kyung Taeck Minn, and Sanya Sukduang for Horizon Therapeutics USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Daniel Knauss and Kyung Taeck Minn - filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Keller, Karen) (Entered: 06/28/2023) (7) |
| Jun 28, 2023 | N/A | SO ORDERED re 11 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Daniel Knauss and Kyung Taeck Minn filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. ORDERED by Judge Maryellen Noreika on 6/28/2023. (dlw) (Entered: 06/28/2023) (0) |
| Jun 20, 2023 | N/A | Pro Hac Vice Attorney Jovial Wong for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/20/2023) (0) |
| Jun 16, 2023 | 7 | Joint STIPULATION Waiving Service and Setting Deadline to Respond to the Complaint by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (Hoeschen, Nathan) (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 8 | NOTICE of Appearance by Dominick T. Gattuso on behalf of Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. (Gattuso, Dominick) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 9 | SO ORDERED re 7 Stipulation Waiving Service and Setting Deadline to Respond to Complaint (Set/Reset Answer Deadlines: Dr. Reddys Laboratories, Inc. answer due 7/14/2023; Dr. Reddys Laboratories, Ltd. answer due 7/14/2023). Signed by Judge Maryellen Noreika on 6/16/2023. (dlw) (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Brian L. O'Gara of Winston & Strawn LLP - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Gattuso, Dominick) (Entered: 06/16/2023) (4) |
| Jun 16, 2023 | N/A | SO ORDERED re 10 MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Brian L. O'Gara of Winston & Strawn LLP filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ORDERED by Judge Maryellen Noreika on 6/16/2023. (dlw) (Entered: 06/16/2023) (0) |
| Jun 16, 2023 | N/A | Pro Hac Vice Attorney Brian O'Gara for Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/16/2023) (0) |
| Jun 14, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 06/14/2023) (0) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Main Document) (10) |
| Jun 7, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 06/07/2023) (3) |
| Jun 7, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/26/2023. Date of Expiration of Patent: 8/3/2023.Thirty Month Stay Deadline: 10/26/2025. (mpb) (Entered: 06/07/2023) (1) |
| Jun 7, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,504,699 B2. (mpb) (Entered: 06/07/2023) (1) |
| Jun 7, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Horizon Therapeutics Capital Limited, Corporate Parent Horizon Therapeutics Finance Sarl for Horizon Therapeutics USA Inc.; Corporate Parent Horizon Therapeutics Holdings Limited for Horizon Therapeutics Ireland DAC filed by Horizon Therapeutics Ireland DAC, Horizon Therapeutics USA Inc.. (mpb) (Entered: 06/07/2023) (2) |
| Jun 7, 2023 | 6 | Summons Issued as to Dr. Reddys Laboratories, Inc. on 6/7/2023; Dr. Reddys Laboratories, Ltd. on 6/7/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 06/07/2023) (Main Document) (2) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Exhibit A) (25) |
| Jun 7, 2023 | 1 | COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ( Filing fee $ 402, receipt number ADEDC-4153448.) - filed by Horizon Therapeutics USA Inc., Horizon Therapeutics Ireland DAC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mpb) (Entered: 06/07/2023) (Civil Cover Sheet) (2) |
| Jun 7, 2023 | 6 | Summons Issued as to Dr. Reddys Laboratories, Inc. on 6/7/2023; Dr. Reddys Laboratories, Ltd. on 6/7/2023. (Attachments: # 1 Summons Issued)(mpb) (Entered: 06/07/2023) (Summons Issued) (2) |
